Alba Sulaj

483 citations
24 papers · 180 indexed · h-index 8
Topics
Pain Mechanisms and Treatments (6 papers)Advanced Glycation End Products research (5 papers)Botulinum Toxin and Related Neurological Disorders (4 papers)

In The Last Decade

Alba Sulaj

21 papers receiving 180 citations

Peers

Alba Sulaj
Comparison fields: 5 of 50
  • Physiology 75
  • Endocrinology, Diabetes and Metabolism 43
  • Molecular Biology 31
  • Radiology, Nuclear Medicine and Imaging 30
  • Neurology 24
Replace Shijun Huang with:
Shijun Huang United States
Takahisa Deguchi Japan
Taichi Tsunekawa Japan
Hirotaka Toshimori Japan
Benjamin Khazan United States
Annie K. McAuley Australia
Laurence Baillet France
Lili Shi China
Takuya Taniguchi Japan
Alba Sulaj relative to Shijun Huang United States Shijun Huang's profile →
Citations per field
00.5×4.5×
Shijun Huang · 1×
Citations per year

Countries citing papers authored by Alba Sulaj

Since Specialization
Citations

This map shows the geographic impact of Alba Sulaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Sulaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Sulaj more than expected).

Fields of papers citing papers by Alba Sulaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Sulaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Sulaj. The network helps show where Alba Sulaj may publish in the future.

Co-authorship network of co-authors of Alba Sulaj

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Sulaj. A scholar is included among the top collaborators of Alba Sulaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Sulaj. Alba Sulaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 6
4 0
5 6
6 9
7 1
8 1
9 5
10 11
11 7
12 1
13 3
14 9
15 17
16 1
17 3
18 14
19 2
20 37

About Alba Sulaj

Alba Sulaj is a scholar working on Clinical Biochemistry, Physiology and Neurology, having authored 24 papers that have together received 180 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (6 papers), Advanced Glycation End Products research (5 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). The work is most often cited by research in Clinical Biochemistry (21 citations), Physiology (75 citations) and Endocrinology, Diabetes and Metabolism (43 citations). Alba Sulaj has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Peter P. Nawroth, Stefan Kopf, Ζoltan Κender, Stephan Herzig, Julia Szendroedi, Varun Kumar, Thomas Fleming, Martin Bendszus, Hermann-Josef Gröne and Dániel Schwarz. Their work appears in journals such as Nucleic Acids Research, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026